Wednesday, July 23, 2025 2:24:26 PM
Reality check on the modular manufacturing issue.
The new regs are designed so one can have mfg at remote sites under control of a central site w/o the huge overhead of full GMP certification of every little remote site.
1) NWBO presently has a single, fairly standard, mfg facility for autologous cellular mfg.
2) Even if Flaskworks was to be used, it is just a variant in the process.
3) The idea NWBO will be using POS mfg anytime soon is whacko. There is a hell of a lot more than just placing an Eden in a hospital and training a tech to feed it. Eden is just one step in the process, It is far from end-to-end.
4) None of this has anything to do with the MAA being approved.
5) The idea that this allows NWBO to expand Specials is more AI dots.
One might envision a future years away where something might play out. But the storyline about this being in play now is whacko.
And one might wonder why the A team is starting to stay approval is not needed. Think hard on that one.
The new regs are designed so one can have mfg at remote sites under control of a central site w/o the huge overhead of full GMP certification of every little remote site.
1) NWBO presently has a single, fairly standard, mfg facility for autologous cellular mfg.
2) Even if Flaskworks was to be used, it is just a variant in the process.
3) The idea NWBO will be using POS mfg anytime soon is whacko. There is a hell of a lot more than just placing an Eden in a hospital and training a tech to feed it. Eden is just one step in the process, It is far from end-to-end.
4) None of this has anything to do with the MAA being approved.
5) The idea that this allows NWBO to expand Specials is more AI dots.
One might envision a future years away where something might play out. But the storyline about this being in play now is whacko.
And one might wonder why the A team is starting to stay approval is not needed. Think hard on that one.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
